Two companion, randomized, placebo-controlled trials of prophylactic vitamin.
A supplementation provided the opportunity to assess the impact of supplementation on malaria parasitemia, morbidity, and mortality in young children in northern Ghana.
In the mortality study, 21 906 children were visited every 4 mo over 2 y, and in the morbidity study 1455 children were visited weekly for 1 y. There was no difference between children supplemented with vitamin A and those given placebo in malaria mortality rates (rate ratio=1.03 ; 95% CI 0.74,1.43) or fever incidence based on reported symptoms.
Malaria parasitemia rates, parasite densities in children with a positive blood smear, and rates of probable malaria illness also did not differ between treatment groups.
There was no correlation between serum retinol at the beginning of the trial and subsequent malaria parasitemia in children who received placebo (r=0.01).
It is concluded that vitamin A supplementation had no impact on malaria in this population.
Mots-clés Pascal : Paludisme, Protozoose, Parasitose, Infection, Morbidité, Mortalité, Prévention, Efficacité traitement, Rétinol, Vitamine, Enfant, Homme, Ghana, Afrique
Mots-clés Pascal anglais : Malaria, Protozoal disease, Parasitosis, Infection, Morbidity, Mortality, Prevention, Treatment efficiency, Retinol, Vitamin, Child, Human, Ghana, Africa
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0319336
Code Inist : 002B05E02B4. Création : 01/03/1996.